Navigation Links
StarClose

ProductsStarClose
Company Abbott Diagnostics
Item StarClose
Features Four Clicks to Close
  • Easy to learn and use
  • 100% Procedure Success in CLIP Study
  • Through-the-Sheath Deployment minimize device exchanges
  • Automated Closure nitinol clip instantly closes Arteriotomy
Extravascular Closure
  • Designed not to impact lumen diameter or distal bloodflow
  • Mechanical Closure hemostais is not clot dependent
  • Nitinol Clip nothing remains in the artery
  • Circumferential provides 360 tissue apposition
Reliable Outcomes
  • Safe, effective closure
  • Rapid Hemostasis CLIP study median time to hemostasis was 16.8 seconds
  • Security hemostasis can be challenged and confirmed on the table
  • Ability to ReAccess/Reclose achieved stasis with 48 clips deployed into a single porcine aorta at 260mmHg
Description StarClose Clip Applier
(includes)
  • Clip Applier
  • 6F Exchange Sheath
  • 6F Dilator
  • 0.038 50 cm J-Tip Guide Wire
    • Info Abbott Diagnostics
    Customer Service: (847) 937-6100
    Web site: http://www.abbottdiagnostics.com/

    Related medicine products :

    1. StarClose Vascular Closure System
    TAG: StarClose
    ... new technology, such as a recessed scratch-resistant ... lens housings, this arthroscope has superior clarity ... EO, Steris and steam autoclaving or soaked ... post/adapters to fit ACMI, Wolf, Dyonics and ...
    ... Laserex Solitaire represents the latest in green laser ... use in both the operating room and clinic. ... is the premium 532nm photocoagulator. , ,The Solitaire ... has the flexibility to deliver up to 2.0 ...
    ... a long-term Transtelephonic dual lead ECG ... is the solution of choice for ... correlation to the patient's ECG./ ... lead loop recording information to satisfy ...
    ... For General Practitioners (GP'S) ... ECGs by phone to a ... 2.5 seconds per lead and ... as rhythm lead. Sequentially transmits ...
    Medicine Products:
    (Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
    (Date:12/5/2009)... launch of International Solutions, an innovative new international private medical insurance ... In addition to offering customers the flexibility to add or remove ... International Solutions enables customers to tailor their benefits to complement those ... ...
    (Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ... Directors has declared a dividend of $0.17 per share of common ... common shareholders of record on December 14, 2009. ... Inc. is a real estate investment and finance company investing in ...
    (Date:12/4/2009)... The American Association of Homes and Services for the ... Community Living and Supportive Services (CLASS) provisions remain in the ... for providing support to elders, people with disabilities and their ... health care reform bill that will make it affordable to ...
    (Date:12/4/2009)... ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information ... for the "Chief Innovation Officer" Appy Award for transforming ... Award recipients are nominated based on their innovative usage ... new levels of customer success to their sales, marketing, ...
    Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
    ... high-resolution panoramic imaging capability to its PreXion3D CBCT ... MATEO, Calif., May 5 PreXion, Inc. ... industrial CT systems, today announced a new high-resolution ... and the PreXion 3D Viewer, the company,s advanced ...
    ... were more likely to get DVT, pulmonary embolisms , , ... level of the protein albumin in urine indicates an ... veins of the lungs and legs, a Dutch study ... thrombosis (DVT), a clotting in the lower extremities which ...
    ... disease, but there,s a promising new procedure being performed at Abington ... ... Abington, PA (PRWEB) May 5, 2009 -- There,s new ... Memorial Hospital where doctors are performing a procedure to bypass, ...
    ... SAN DIEGO, May 5 ResMed Inc. (NYSE: RMD ... healthcare conferences. Kieran Gallahue, President and CEO will present at the ... New York Palace Hotel in New York City on May 13, ... Organization Development and General Counsel will present at the Deutsche Bank ...
    ... in Boulder, CO, and the Influenza Division of the Centers ... that the M gene version of InDevR,s FluChip can detect ... seasonal influenza viruses (A/H1N1 and A/H3N2) as well as the ... a joint team of scientists at the University of Colorado ...
    ... says, , , TUESDAY, May 5 (HealthDay News) -- Babies ... much greater chance of developing a respiratory tract infection, ... Permanente found an increased risk for the infection -- ... among premature infants who are put on oxygen or ...
    Other Medicine News:Health News:PreXion Adds High-resolution Panoramic Imaging 2Health News:Urine Test Predicts Vein Clot Risk 2Health News:Urine Test Predicts Vein Clot Risk 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 2Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 4Health News:InDevR's FluChip detects and distinguishes swine-origin H1N1 from human influenza viruses 2Health News:Even Barely Early Babies Face Respiratory Risks 2
    (Date:12/4/2009)... Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an ... and Drug Administration seeking approval to market its 8mg ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ...
    (Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
    (Date:12/3/2009)... Pa., Dec. 3 Ambry Genetics and SoftGenetics ... provide extended bioinformatics genomics services using SoftGenetics, NextGENe ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ) ... team at Ambry has been providing genomics solutions ...
    Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 1PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 2PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 3Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 1Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 2Booth Radiology Extends and Elevates Partnership With AMICAS 52747 1Booth Radiology Extends and Elevates Partnership With AMICAS 52747 2Booth Radiology Extends and Elevates Partnership With AMICAS 52747 3